These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 18513434

  • 1. Diagnostic utility of LunX mRNA in peripheral blood and pleural fluid in patients with primary non-small cell lung cancer.
    Cheng M, Chen Y, Yu X, Tian Z, Wei H.
    BMC Cancer; 2008 May 31; 8():156. PubMed ID: 18513434
    [Abstract] [Full Text] [Related]

  • 2. Relationship between circulating lung-specific X protein messenger ribonucleic acid expression and micrometastasis and prognosis in patients with early-stage nonsmall cell lung cancer.
    Cui Y, Wang W, Yao S, Qiu Z, Cong L.
    J Cancer Res Ther; 2020 May 31; 16(7):1641-1647. PubMed ID: 33565511
    [Abstract] [Full Text] [Related]

  • 3. Diagnostic utility of LUNX mRNA and VEGF mRNA in pleural fluid for differentiating benign from malignant origin.
    Bao QL, Li J, Sun W, Jiang HG, Zhu LR, Wang Y.
    Jpn J Clin Oncol; 2014 Dec 31; 44(12):1198-205. PubMed ID: 25425729
    [Abstract] [Full Text] [Related]

  • 4. Detection of CK19, LUNX, and KS1/4 mRNA expression in the peripheral blood for diagnosis of micrometastases in patients with non-small cell lung cancer and their clinical implications.
    Yan L, Yao Y, Wang LH, Wang ML, Fu XH.
    Genet Mol Res; 2015 Nov 25; 14(4):15090-5. PubMed ID: 26634471
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Multiplex PCR-based detection of circulating tumor cells in lung cancer patients using CK19, PTHrP, and LUNX specific primers.
    Katseli A, Maragos H, Nezos A, Syrigos K, Koutsilieris M.
    Clin Lung Cancer; 2013 Sep 25; 14(5):513-20. PubMed ID: 23810363
    [Abstract] [Full Text] [Related]

  • 7. Superiority and clinical significance of Lunx mRNA in the diagnosis of malignant pleural effusion caused by pulmonary carcinoma.
    Tang Y, Xu L.
    J Exp Clin Cancer Res; 2013 Jun 08; 32(1):37. PubMed ID: 23759037
    [Abstract] [Full Text] [Related]

  • 8. LUNX mRNA-positive cells at different time points predict prognosis in patients with surgically resected nonsmall cell lung cancer.
    Li J, Shi SB, Shi WL, Wang Y, Yu LC, Zhu LR, Ge LP.
    Transl Res; 2014 Jan 08; 163(1):27-35. PubMed ID: 24120632
    [Abstract] [Full Text] [Related]

  • 9. [LUNX mRNA in regional lymph nodes of non-small cell lung cancer patients by RT-PCR and its clinical significance].
    Tan S, Cheng Z, Ma Y, Tan S, Yin Z, Hu W, Yu F.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2010 Dec 08; 35(12):1236-41. PubMed ID: 21200090
    [Abstract] [Full Text] [Related]

  • 10. [Correlation between the mRNA levels of BCRP and LUNX genes and pathological types and stages of patients with non-small cell lung cancer].
    Chen D, Han W, Wang P, Ma H.
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2023 Feb 10; 40(2):202-207. PubMed ID: 36709941
    [Abstract] [Full Text] [Related]

  • 11. Expression and clinical significance of lung-specific X protein mRNA in bronchial brushing specimens from patients with or without lung cancer.
    Lv M, Wu MZ, Zhao YJ, Yang DI, Wang EH, Wu GP.
    Respirology; 2011 Oct 10; 16(7):1076-80. PubMed ID: 21651644
    [Abstract] [Full Text] [Related]

  • 12. Lunx is a superior molecular marker for detection of non-small cell lung cancer in peripheral blood [corrected].
    Mitas M, Hoover L, Silvestri G, Reed C, Green M, Turrisi AT, Sherman C, Mikhitarian K, Cole DJ, Block MI, Gillanders WE.
    J Mol Diagn; 2003 Nov 10; 5(4):237-42. PubMed ID: 14573783
    [Abstract] [Full Text] [Related]

  • 13. Isolation of a novel human lung-specific gene, LUNX, a potential molecular marker for detection of micrometastasis in non-small-cell lung cancer.
    Iwao K, Watanabe T, Fujiwara Y, Takami K, Kodama K, Higashiyama M, Yokouchi H, Ozaki K, Monden M, Tanigami A.
    Int J Cancer; 2001 Feb 15; 91(4):433-7. PubMed ID: 11251963
    [Abstract] [Full Text] [Related]

  • 14. Midkine mRNA level in peripheral blood mononuclear cells is a novel biomarker for primary non-small cell lung cancer: a prospective study.
    Ma Z, Li H, Wang B, Shen Q, Cui E, Min L, Qian F, Ping J, Dai L.
    J Cancer Res Clin Oncol; 2013 Apr 15; 139(4):557-62. PubMed ID: 23224432
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Feasibility and its clinical significance of detection of LUNX mRNA expression in diagnosis of micrometastasis for non-small cell lung cancer].
    Zhang P, Liu Y, Chen J, Song S, Shang Z.
    Zhongguo Fei Ai Za Zhi; 2006 Dec 20; 9(6):506-10. PubMed ID: 21182811
    [Abstract] [Full Text] [Related]

  • 19. Combined detection of CEA, CK-19 and c-met mRNAs in peripheral blood: a highly sensitive panel for potential molecular diagnosis of non-small cell lung cancer.
    Sheu CC, Chang MY, Chang HC, Tsai JR, Lin SR, Chang SJ, Hwang JJ, Huang MS, Chong IW.
    Oncology; 2006 Dec 20; 70(3):203-11. PubMed ID: 16809939
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.